Edition:
United States

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

2.25USD
14 Feb 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.25
Open
$2.51
Day's High
$2.51
Day's Low
$2.51
Volume
37
Avg. Vol
5,528
52-wk High
$3.91
52-wk Low
$1.43

Chart for

About

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action,... (more)
No analyst recommendations are available for .

Overall

Beta: -0.08
Market Cap(Mil.): $13.38
Shares Outstanding(Mil.): 5.14
Dividend: --
Yield (%): --

Financials

  XTLB.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -1.00 -- --
ROI: -70.95 8.92 14.45
ROE: -125.01 10.08 15.96

Earnings vs. Estimates